These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
474 related items for PubMed ID: 9439455
1. Protein tyrosine phosphatase-like protein IA2-antibodies plus glutamic acid decarboxylase 65 antibodies (GADA) indicates autoimmunity as frequently as islet cell antibodies assay in children with recently diagnosed diabetes mellitus. Borg H, Fernlund P, Sundkvist G. Clin Chem; 1997 Dec; 43(12):2358-63. PubMed ID: 9439455 [Abstract] [Full Text] [Related]
2. Islet cell antibody frequency differs from that of glutamic acid decarboxylase antibodies/IA2 antibodies after diagnosis of diabetes. Borg H, Marcus C, Sjöblad S, Fernlund P, Sundkvist G. Acta Paediatr; 2000 Jan; 89(1):46-51. PubMed ID: 10677057 [Abstract] [Full Text] [Related]
3. GADIA2-combi determination as first-line screening for improved prediction of type 1 diabetes in relatives. Dittler J, Seidel D, Schenker M, Ziegler AG. Diabetes; 1998 Apr; 47(4):592-7. PubMed ID: 9568692 [Abstract] [Full Text] [Related]
4. Identification of protein tyrosine phosphatase-like IA2 (islet cell antigen 512) as the insulin-dependent diabetes-related 37/40K autoantigen and a target of islet-cell antibodies. Bonifacio E, Lampasona V, Genovese S, Ferrari M, Bosi E. J Immunol; 1995 Dec 01; 155(11):5419-26. PubMed ID: 7594559 [Abstract] [Full Text] [Related]
5. Combined screening for autoantibodies to IA-2 and antibodies to glutamic acid decarboxylase in first degree relatives of patients with IDDM. The DENIS Study Group. Deutsche Nikotinamid Interventions-Studie. Seissler J, Morgenthaler NG, Achenbach P, Lampeter EF, Glawe D, Payton M, Christie M, Scherbaum WA. Diabetologia; 1996 Nov 01; 39(11):1351-6. PubMed ID: 8933004 [Abstract] [Full Text] [Related]
6. MHC class I chain-related gene-A is associated with IA2 and IAA but not GAD in Swedish type 1 diabetes mellitus. Gupta M, Graham J, McNeeny B, Zarghami M, Landin-Olsson M, Hagopian WA, Palmer J, Lernmark A, Sanjeevi CB. Ann N Y Acad Sci; 2006 Oct 01; 1079():229-39. PubMed ID: 17130560 [Abstract] [Full Text] [Related]
7. High levels of antigen-specific islet antibodies predict future beta-cell failure in patients with onset of diabetes in adult age. Borg H, Gottsäter A, Landin-Olsson M, Fernlund P, Sundkvist G. J Clin Endocrinol Metab; 2001 Jul 01; 86(7):3032-8. PubMed ID: 11443164 [Abstract] [Full Text] [Related]
8. Antibodies to the tyrosine phosphatase-like protein IA-2 are highly associated with IDDM, but not with autoimmune endocrine diseases or stiff man syndrome. Morgenthaler NG, Seissler J, Achenbach P, Glawe D, Payton M, Meinck HM, Christie MR, Scherbaum WA. Autoimmunity; 1997 Jul 01; 25(4):203-11. PubMed ID: 9344328 [Abstract] [Full Text] [Related]
9. IA-2 antibodies--a sensitive marker of IDDM with clinical onset in childhood and adolescence. Childhood Diabetes in Finland Study Group. Savola K, Bonifacio E, Sabbah E, Kulmala P, Vähäsalo P, Karjalainen J, Tuomilehto-Wolf E, Meriläinen J, Akerblom HK, Knip M. Diabetologia; 1998 Apr 01; 41(4):424-9. PubMed ID: 9562346 [Abstract] [Full Text] [Related]
10. Pancreatic islet cell cytoplasmic antibody in diabetes is represented by antibodies to islet cell antigen 512 and glutamic acid decarboxylase. Myers MA, Rabin DU, Rowley MJ. Diabetes; 1995 Nov 01; 44(11):1290-5. PubMed ID: 7589826 [Abstract] [Full Text] [Related]
14. Glutamic acid decarboxylase and ICA512/IA-2 autoantibodies as disease markers and relationship to residual beta-cell function and glycemic control in young type 1 diabetic patients. Zanone MM, Catalfamo E, Pietropaolo SL, Rabbone I, Sacchetti C, Cerutti F, Trucco M, Cavallo-Perin P. Metabolism; 2003 Jan 01; 52(1):25-9. PubMed ID: 12524658 [Abstract] [Full Text] [Related]
16. Prediction of insulin-dependent diabetes mellitus in siblings of children with diabetes. A population-based study. The Childhood Diabetes in Finland Study Group. Kulmala P, Savola K, Petersen JS, Vähäsalo P, Karjalainen J, Löppönen T, Dyrberg T, Akerblom HK, Knip M. J Clin Invest; 1998 Jan 15; 101(2):327-36. PubMed ID: 9435304 [Abstract] [Full Text] [Related]
17. International Workshop on Lessons From Animal Models for Human Type 1 Diabetes: identification of insulin but not glutamic acid decarboxylase or IA-2 as specific autoantigens of humoral autoimmunity in nonobese diabetic mice. Bonifacio E, Atkinson M, Eisenbarth G, Serreze D, Kay TW, Lee-Chan E, Singh B. Diabetes; 2001 Nov 15; 50(11):2451-8. PubMed ID: 11679421 [Abstract] [Full Text] [Related]
18. Islet cell antibodies represent autoimmune response against several antigens. Månsson L, Törn C, Landin-Olsson M. Int J Exp Diabetes Res; 2001 Nov 15; 2(2):85-90. PubMed ID: 12369720 [Abstract] [Full Text] [Related]
19. Low prevalence of GAD and IA2 antibodies in schoolchildren from a village in the southwestern section of the Netherlands. Batstra MR, Petersen JS, Bruining GJ, Grobbee DE, de Man SA, Molenaar JL, Dyrberg T, Aanstoot HJ. Hum Immunol; 2001 Oct 15; 62(10):1106-10. PubMed ID: 11600217 [Abstract] [Full Text] [Related]
20. Combined analysis and single-step detection of GAD65 and IA2 autoantibodies in IDDM can replace the histochemical islet cell antibody test. Wiest-Ladenburger U, Hartmann R, Hartmann U, Berling K, Böhm BO, Richter W. Diabetes; 1997 Apr 15; 46(4):565-71. PubMed ID: 9075795 [Abstract] [Full Text] [Related] Page: [Next] [New Search]